BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9728328)

  • 1. Sphingolipids and cell signalling.
    Fredman P
    J Inherit Metab Dis; 1998 Aug; 21(5):472-80. PubMed ID: 9728328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
    Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
    J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipid metabolites in neural signalling and function.
    Colombaioni L; Garcia-Gil M
    Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A view on sphingolipids and disease.
    Kolter T
    Chem Phys Lipids; 2011 Sep; 164(6):590-606. PubMed ID: 21570958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology and current treatment of neurodegenerative sphingolipidoses.
    Eckhardt M
    Neuromolecular Med; 2010 Dec; 12(4):362-82. PubMed ID: 20730629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids in mammalian cell signalling.
    Ohanian J; Ohanian V
    Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. My journey into the world of sphingolipids and sphingolipidoses.
    Sandhoff K
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sphingolipids, vehicle for pathogenic agents and cause of genetic diseases].
    Fasano C; Hiol A; Miolan JP; Niel JP
    Med Sci (Paris); 2006 Apr; 22(4):411-5. PubMed ID: 16597411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage diseases: new insights into sphingolipid functions.
    Sillence DJ; Platt FM
    Trends Cell Biol; 2003 Apr; 13(4):195-203. PubMed ID: 12667757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the biochemistry of sphingolipidoses.
    Kolter T; Sandhoff K
    Brain Pathol; 1998 Jan; 8(1):79-100. PubMed ID: 9458169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease.
    Allende ML; Zhu H; Kono M; Hoachlander-Hobby LE; Huso VL; Proia RL
    Cell Signal; 2021 Feb; 78():109879. PubMed ID: 33296739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond a structural component: sphingolipids in immunology.
    Prieschl EE; Baumruker T
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders.
    Sural-Fehr T; Bongarzone ER
    J Neurosci Res; 2016 Nov; 94(11):1042-8. PubMed ID: 27638590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of brain innate immune response in lysosomal storage disorders: fundamental process or evolutionary side effect?
    Vitner EB
    FEBS Lett; 2020 Nov; 594(22):3619-3631. PubMed ID: 33131047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
    Hannun YA; Linardic CM
    Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K; Kolter T; Van Echten-Deckert G
    Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.